Staar Surgical Co. (STAA) Sets New 12-Month High at $9.47
Shares of Staar Surgical Co. (NASDAQ:STAA) hit a new 52-week high during trading on Monday . The stock traded as high as $9.47 and last traded at $9.45, with a volume of 126,593 shares trading hands. The stock had previously closed at $8.89.
STAA has been the topic of a number of research reports. Zacks Investment Research upgraded shares of Staar Surgical from a “hold” rating to a “buy” rating and set a $9.50 price target on the stock in a report on Saturday, August 6th. Stephens downgraded shares of Staar Surgical from an “overweight” rating to an “equal weight” rating in a report on Thursday, May 12th. Canaccord Genuity reiterated a “hold” rating and issued a $7.00 price target on shares of Staar Surgical in a report on Thursday, May 12th. William Blair reiterated a “market perform” rating on shares of Staar Surgical in a report on Thursday, August 4th. Finally, Benchmark Co. upgraded shares of Staar Surgical from a “hold” rating to a “buy” rating and set a $6.00 price target on the stock in a report on Wednesday, May 18th. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $7.50.
The company has a 50-day moving average price of $6.85 and a 200 day moving average price of $6.67. The firm’s market capitalization is $372.37 million.
Staar Surgical (NASDAQ:STAA) last issued its quarterly earnings results on Wednesday, August 3rd. The company reported ($0.05) earnings per share for the quarter, hitting the Zacks’ consensus estimate of ($0.05). The company earned $21 million during the quarter, compared to analysts’ expectations of $19.88 million. Staar Surgical’s quarterly revenue was up 12.4% on a year-over-year basis. Equities analysts anticipate that Staar Surgical Co. will post ($0.31) earnings per share for the current fiscal year.
In other Staar Surgical news, Director Richard A. Meier sold 25,000 shares of the firm’s stock in a transaction dated Friday, May 20th. The stock was sold at an average price of $5.35, for a total transaction of $133,750.00. Following the completion of the sale, the director now directly owns 27,149 shares in the company, valued at approximately $145,247.15. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder Broadwood Partners Lp acquired 14,144 shares of the firm’s stock in a transaction on Wednesday, June 29th. The shares were acquired at an average price of $5.24 per share, with a total value of $74,114.56. The disclosure for this purchase can be found here.
An institutional investor recently raised its position in Staar Surgical stock. Mutual of America Capital Management LLC raised its position in Staar Surgical Co. (NASDAQ:STAA) by 0.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 216,682 shares of the company’s stock after buying an additional 1,299 shares during the period. Mutual of America Capital Management LLC owned 0.54% of Staar Surgical worth $1,547,000 at the end of the most recent quarter.
STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses (IOLs) used in cataract surgery and implantable collamer lenses (ICLs) used in refractive surgery.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.